Kardiyak Donör Seçimi ve Bakımı
Özet
Kalp nakli, ileri evre kalp yetmezliği olan hastalarda yerleşik, etkin ve standart bir tedavi seçeneğidir. Yenilikçi deneysel girişimlerden uzun dönemli klinik başarıya uzanan bu süreç; cerrahi disiplin, organizasyonel gelişmeler ve multidisipliner iş birliğinin bir ürünüdür. Bu sayede cerrahi teknikler, organ koruma yöntemleri, immünsupresyon stratejileri, organ bağışı ve dağıtım sistemleri, enfeksiyon kontrolü ve uzun dönem greft izlemi gibi birçok alanda kayda değer ilerlemeler sağlanmıştır.
Geleneksel olarak “standart kriterler” optimal donör kalbin tanımlanmasında temel alınmıştır. Ancak, nakil listesine alınan hasta sayısının dünya genelinde hızla artması nedeniyle, donör havuzunu genişletmek amacıyla genişletilmiş kriterli donörlerin kullanımı giderek yaygınlaşmaktadır. Bununla birlikte, Türkiye gibi bazı ülkelerde güçlü bir sağlık altyapısına rağmen donör yetersizliği ve aile onayı oranlarının düşüklüğü önemli engeller olmaya devam etmektedir.
Kardiyak donör seçimi ve bakımı, nakil başarısını doğrudan belirleyen en kritik basamaklardan biridir. Beyin ölümü, kalp de dahil olmak üzere birçok organda kompleks patofizyolojik değişikliklere yol açar. Bu süreçlerin anlaşılması ve uygun yönetim stratejilerinin uygulanması, donör organ fonksiyonunun korunması ve transplantasyon sonuçlarının iyileştirilmesi açısından yaşamsal öneme sahiptir.
Donör değerlendirmesinde immünolojik uyum, yaş, cinsiyet, sol ventrikül fonksiyonu, hemodinamik parametreler, biyomarker düzeyleri (troponin, BNP/NT-proBNP), komorbiditeler, koroner arter hastalığı ve enfeksiyon varlığı dikkate alınmalıdır. Ekokardiyografi ve gerekli durumlarda koroner anjiyografi, donör kalbin uygunluğunu belirlemede temel yöntemlerdir. Özellikle koroner arter hastalığı riski yüksek donörlerde anjiyografik değerlendirme önerilmektedir. Ayrıca, donör–alıcı boyut eşleştirmesinde tahmini kalp kütlesi yönteminin kullanılması ve beyin ölümü sonrası gelişen kardiyak disfonksiyonun yoğun bakım tedavisi ile düzeltilebileceği bildirilmektedir.
Donör bakımında ventilatör stratejileri, normoterminin korunması, sıvı-elektrolit dengesinin sağlanması, enfeksiyon profilaksisi, hormonal destek tedavileri ve hiperoksiden kaçınılması kritik öneme sahiptir. Uygun alıcı seçimi ile marjinal donörlerin güvenle kullanılabileceğine dair kanıtlar giderek artmaktadır.
Kalp nakli alanı; organ koruma teknolojilerindeki ilerlemeler, lojistik optimizasyon, soğuk iskemi süresinin azaltılması, mitokondriyal transplantasyon, dolaşım durması sonrası donör kullanımının artışı ve organ dağıtım politikalarındaki güncellemeler ile sürekli gelişmektedir. Bu nedenle, donör seçimi stratejilerinin ve risk öngörü modellerinin dinamik biçimde güncellenmesi, nakil sonuçlarının daha da iyileştirilmesi açısından kritik öneme sahiptir.
Referanslar
Copeland H, Knezevic I, Baran DA, Rao V, Pham M, Gustafsson F, et al. Donor heart selection: Evidence-based guidelines for providers. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2023;42(1):7-29.
Velleca A, Shullo MA, Dhital K, Azeka E, Colvin M, DePasquale E, et al. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2023;42(5):e1-e141.
Jain R, Kransdorf EP, Cowger J, Jeevanandam V, Kobashigawa JA. Donor Selection for Heart Transplantation in 2025. JACC Heart Fail. 2025;13(3):389-401.
Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK. Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-of-the-Art Review. Circulation. 2018;137(1):71-87.
Aliabadi-Zuckermann AZ, Gokler J, Kaider A, Riebandt J, Moayedifar R, Osorio E, et al. Donor heart selection and outcomes: An analysis of over 2,000 cases. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018;37(8):976-84.
Khush KK, Ball RL. Great variability in donor heart acceptance practices across the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020;20(6):1582-96.
Moayedi Y, Rodenas-Alesina E, Mueller B, Fan CS, Cherikh WS, Stehlik J, et al. Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk. Circulation Heart failure. 2023;16(5):e009994.
Wayda B, Angleitner P, Smits JM, van Kins A, Berchtold-Herz M, De Pauw M, et al. Disparities in donor heart acceptance between the USA and Europe: clinical implications. European heart journal. 2023;44(44):4665-74.
Baran DA, Long A, Lansinger J, Copeland JG, Copeland H. Donor Utilization in the Recent Era: Effect of Sex, Drugs, and Increased Risk. Circulation Heart failure. 2022;15(7):e009547.
Khush KK, Zaroff JG, Nguyen J, Menza R, Goldstein BA. National decline in donor heart utilization with regional variability: 1995-2010. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2015;15(3):642-9.
Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. The New England journal of medicine. 2004;351(26):2730-9.
Hyun J, Lee SE, Kim JJ. Management of potential cardiac donors. Clin Transplant Res. 2024;38(1):37-45.
Wijdicks EF. The diagnosis of brain death. N Engl J Med. 2001;344(16):1215-21.
Burkle CM, Sharp RR, Wijdicks EF. Why brain death is considered death and why there should be no confusion. Neurology. 2014;83(16):1464-9.
Lewis A, Bernat JL, Blosser S, Bonnie RJ, Epstein LG, Hutchins J, et al. An interdisciplinary response to contemporary concerns about brain death determination. Neurology. 2018;90(9):423-6.
Bernat JL. Brain death is a scientific concept. Lancet. 2010;375(9714):554; author reply
Danovitch GM, Delmonico FL. Determination of Brain Death. The New England journal of medicine. 2022;386(16):e44.
Greer DM. Determination of Brain Death. The New England journal of medicine. 2021;385(27):2554-61.
Magnus DC, Wilfond BS, Caplan AL. Accepting brain death. The New England journal of medicine. 2014;370(10):891-4.
Lewis A, Kirschen MP, Greer D. The 2023 AAN/AAP/CNS/SCCM Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline: A Comparison With the 2010 and 2011 Guidelines. Neurol Clin Pract. 2023;13(6):e200189.
Greer DM, Kirschen MP, Lewis A, Gronseth GS, Rae-Grant A, Ashwal S, et al. Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline. Neurology. 2023;101(24):1112-32.
Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA : the journal of the American Medical Association. 2020;324(11):1078-97.
Nagy A, Szecsi B, Eke C, Szabo A, Mihaly S, Fazekas L, et al. Endocrine Management and Hormone Replacement Therapy in Cardiac Donor Management: A Retrospective Observational Study. Transplantation proceedings. 2021;53(10):2807-15.
Zimpfer D, Alexander PMA, Davies RR, Dipchand AI, Feingold B, Joong A, et al. Pediatric donor management to optimize donor heart utilization. Pediatric transplantation. 2020;24(3):e13679.
Dhar R, Cotton C, Coleman J, Brockmeier D, Kappel D, Marklin G, et al. Comparison of high- and low-dose corticosteroid regimens for organ donor management. J Crit Care. 2013;28(1):111 e1-7.
Cypel M, Keshavjee S. Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion. Current opinion in organ transplantation. 2013;18(5):513-7.
Ullah S, Zabala L, Watkins B, Schmitz ML. Cardiac organ donor management. Perfusion. 2006;21(2):93-8.
Chamorro C, Silva JA, Romera MA. Cardiac donor management: another point of view. Transplantation proceedings. 2003;35(5):1935-7.
Delgado DH, Rao V, Ross HJ. Donor management in cardiac transplantation. The Canadian journal of cardiology. 2002;18(11):1217-23.
Rodeheffer RJ, Naftel DC, Stevenson LW, Porter CB, Young JB, Miller LW, et al. Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group. Circulation. 1996;94(11):2883-9.
Copeland JG. Only optimal donors should be accepted for heart transplantation: protagonist. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1995;14(6 Pt 1):1038-42.
Wayda B, Luikart H, Weng Y, Zhang S, Neidlinger N, Wood RP, et al. Reasons for donor heart offer refusal in the United States: Results from 14,132 transplant clinician surveys in the Donor Heart Study. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2025;44(7):1075-82.
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577-84.
Tolmie SB, Gibbons RD, Anderson AS, Khush KK, Chhikara K, Churpek M, et al. Association of the 2018 U.S. Heart Allocation Policy Change and the Survival Benefit of Heart Transplantation. JACC Heart Fail. 2025;13(7):102480.
Guenther SPW, Schramm R, Teuteberg JJ, Shudo Y, Rogge AL, Schaeper KE, et al. Which Donor and Recipient Risk Factors Matter in Heart Transplantation? Results From a Survey of 53 Centers Across Five Countries. Clinical transplantation. 2025;39(6):e70214.
Matesanz R, Marazuela R, Dominguez-Gil B, Coll E, Mahillo B, de la Rosa G. The 40 donors per million population plan: an action plan for improvement of organ donation and transplantation in Spain. Transplantation proceedings. 2009;41(8):3453-6.
Matesanz R, Marazuela R, Coll E, Mahillo B, Dominguez-Gil B. About the Opt-Out System, Live Transplantation, and Information to the Public on Organ Donation in Spain ... Y ole! American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2017;17(6):1695-6.
Matesanz R, Dominguez-Gil B, Coll E, Mahillo B, Marazuela R. How Spain Reached 40 Deceased Organ Donors per Million Population. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2017;17(6):1447-54.
Matesanz R, Dominguez-Gil B, Marazuela R, Coll E, de la Rosa G. Benchmarking in organ donation after brain death in Spain. Lancet. 2012;380(9842):649-50.
Dominguez-Gil B, Haase-Kromwijk B, Van Leiden H, Neuberger J, Coene L, Morel P, et al. Current situation of donation after circulatory death in European countries. Transplant international : official journal of the European Society for Organ Transplantation. 2011;24(7):676-86.
Groba Marco MDV, Cabrera Santana M, Galvan Ruiz M, Fernandez de Sanmamed M, Romero Lujan JL, Gonzalez Martin JM, et al. Expanding Horizons in Cardiac Transplant: Efficacy and Outcomes of Circulatory and Brain Death Donor Hearts in a Newly Implemented Cardiac Transplant Program with Limited Donor Accessibility and a Literature Review. J Clin Med. 2024;13(17).
Shah KS, Kittleson MM, Kobashigawa JA. Updates on Heart Transplantation. Curr Heart Fail Rep. 2019;16(5):150-6.
Ribeiro RVP, Alvarez JS, Yu F, Paradiso E, Adamson MB, Maria Ruggeri G, et al. Hearts Donated After Circulatory Death and Reconditioned Using Normothermic Regional Perfusion Can Be Successfully Transplanted Following an Extended Period of Static Storage. Circulation Heart failure. 2019;12(4):e005364.
Beuth J, Falter F, Pinto Ribeiro RV, Badiwala M, Meineri M. New Strategies to Expand and Optimize Heart Donor Pool: Ex Vivo Heart Perfusion and Donation After Circulatory Death: A Review of Current Research and Future Trends. Anesth Analg. 2019;128(3):406-13.
DePasquale EC, Schweiger M, Ross HJ. A contemporary review of adult heart transplantation: 2012 to 2013. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2014;33(8):775-84.
Reyentovich A, Leacche M, Moazami N. DCD Heart Transplantation with NRP: Excellent Results and a Continued Uphill Battle. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2025.
Messer S, Page A, Axell R, Berman M, Hernandez-Sanchez J, Colah S, et al. Outcome after heart transplantation from donation after circulatory-determined death donors. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(12):1311-8.
Meyer DM, Nayak A, Wood KL, Blumer V, Schettle S, Salerno C, et al. The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients. The Annals of thoracic surgery. 2025;119(1):34-58.
Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, et al. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2019;38(8):858-69.
Yagdi T, Oguz E, Engin C, Engin Y, Nalbantgil S, Zoghi M, et al. Changing face of heart failure surgery. Transplant Proc. 2012;44(6):1729-31.
Tore Altun G, Corman Dincer P, Birtan D, Arslantas R, Kasap Yakin D, Ozdemir I, et al. Reasons Why Organs From Deceased Donors Were Not Accepted for Transplantation. Transplantation proceedings. 2019;51(7):2202-4.
Yagdi T, Nalbantgil S, Ozbaran M. [Heart transplantation: preoperative evaluation, perioperative management, postoperative follow-up]. Turk Kardiyol Dern Ars. 2015;43(1):95-108.
Erbasan O, Koksel U, Bayezid O. Kalp Transplantasyonu için Resipient ve Donör Seçimi, Donör-Resipient Uyumu. In: Bayezid O, editor. Kalp & Akciğer Transplantasyonu. Antalya: Akdeniz Üniversitesi; 2010. p. 99-137.
Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, et al. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Critical care medicine. 2015;43(6):1291-325.
A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968;205(6):337-40.
Diagnosis of brain death. Statement issued by the honorary secretary of the Conference of Medical Royal Colleges and their Faculties in the United Kingdom on 11 October 1976. Br Med J. 1976;2(6045):1187-8.
Landmark article Aug 5, 1968: A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death. JAMA. 1984;252(5):677-9.
Stehlik J, J. L. Cardiac transplantation: Overview. In: Domanski MJ, Mehra MR, M.A. P, editors. Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation. United Kingdom: Oxford University Press; 2016. p. 255-78.
Kwon YIC, Keller M, Elhigzi K, Adibi I, Jones HC, Lai A, et al. Early Outcomes of Primary Graft Dysfunction Comparing Donation After Circulatory and Brain Death Heart Transplantation: An Analysis of the UNOS Registry. Clinical transplantation. 2025;39(7):e70222.
Khush KK, Malinoski D, Luikart H, Wayda B, Groat T, Nguyen J, et al. Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart Study. Circulation. 2023;148(10):822-33.
Cohen O, De La Zerda DJ, Beygui R, Hekmat D, Laks H. Donor brain death mechanisms and outcomes after heart transplantation. Transplantation proceedings. 2007;39(10):2964-9.
Nguyen A, Rana A, Shafii A, Loor G, Civitello A, Reyes JEM, et al. Potential intermediate-term survival differences among heart transplant recipients from circulatory death vs brain death donors. JHLT Open. 2025;9:100342.
Atkinson C, Floerchinger B, Qiao F, Casey S, Williamson T, Moseley E, et al. Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts. Circulation. 2013;127(12):1290-9.
Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation. 2000;102(19):2426-33.
Bittner HB, Chen EP, Milano CA, Kendall SW, Jennings RB, Sabiston DC, Jr., et al. Myocardial beta-adrenergic receptor function and high-energy phosphates in brain death--related cardiac dysfunction. Circulation. 1995;92(9 Suppl):II472-8.
Galinanes M, Smolenski RT, Hearse DJ. Brain death-induced cardiac contractile dysfunction and long-term cardiac preservation. Rat heart studies of the effects of hypophysectomy. Circulation. 1993;88(5 Pt 2):II270-80.
Smith M. Physiologic changes during brain stem death--lessons for management of the organ donor. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2004;23(9 Suppl):S217-22.
Boone M, Deen PM. Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption. Pflugers Arch. 2008;456(6):1005-24.
Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59(1):58-62.
Kinoshita Y, Okamoto K, Yahata K, Yoshioka T, Sugimoto T, Kawaguchi N, et al. Clinical and pathological changes of the heart in brain death maintained with vasopressin and epinephrine. Pathol Res Pract. 1990;186(1):173-9.
Iwai A, Sakano T, Uenishi M, Sugimoto H, Yoshioka T, Sugimoto T. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation. 1989;48(4):613-7.
Mascia L, Mastromauro I, Viberti S, Vincenzi M, Zanello M. Management to optimize organ procurement in brain dead donors. Minerva Anestesiol. 2009;75(3):125-33.
Lewis A. An Update on Brain Death/Death by Neurologic Criteria since the World Brain Death Project. Semin Neurol. 2024;44(3):236-62.
Dorent R, Gandjbakhch E, Goeminne C, Ivanes F, Sebbag L, Bauer F, et al. Assessment of potential heart donors: A statement from the French heart transplant community. Arch Cardiovasc Dis. 2018;111(2):126-39.
Griepp RB, Stinson EB, Clark DA, Dong E, Jr., Shumway NE. The cardiac donor. Surgery, gynecology & obstetrics. 1971;133(5):792-8.
Copeland JG, Stinson EB. Human heart transplantation. Curr Probl Cardiol. 1979;4(8):1-5.
Griepp RB, Stinson EB, Bieber CP, Reitz BA, Copeland JG, Oyer PE, et al. Human heart transplantation: current status. The Annals of thoracic surgery. 1976;22(2):171-5.
Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D'Alessandro A, Dec GW, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002;106(7):836-41.
Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, et al. Donor scoring system for heart transplantation and the impact on patient survival. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2012;31(4):387-97.
Fagerstrom K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs. 2002;62 Suppl 2:1-9.
Ali AA, Lim E, Thanikachalam M, Sudarshan C, White P, Parameshwar J, et al. Cardiac arrest in the organ donor does not negatively influence recipient survival after heart transplantation. Eur J Cardiothorac Surg. 2007;31(5):929-33.
Stehlik J, Feldman DS, Brown RN, VanBakel AB, Russel SD, Ewald GA, et al. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2010;29(3):291-8.
Costa D, Picascia A, Grimaldi V, Amarelli C, Petraio A, Levi A, et al. Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy. Transplant immunology. 2024;83:102011.
Thompson JS, Thacker LR, 2nd, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation. 2000;69(10):2178-86.
Khaghani A, Yacoub M, McCloskey D, Awad J, Burden M, Fitzgerald M, et al. The influence of HLA matching, donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporin A and azathioprine. Transplantation proceedings. 1989;21(1 Pt 1):799-800.
Festenstein H, Banner N, Smith J, Awad J, Burden M, Fitzgerald N, et al. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine. Transplantation proceedings. 1989;21(1 Pt 1):797-8.
Lick SD, Beckles DL, Piovesana G, Vaidya S, Indrikovs A, Barbagelata NA, et al. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. The Annals of thoracic surgery. 2011;92(4):1428-34.
Lick SD, Vaidya S, Kollar AC, Boor PJ, Vertrees RA. Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device support. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2008;27(9):1036-9.
Han J, Rushakoff J, Moayedi Y, Henricksen E, Lee R, Luikart H, et al. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2024;43(3):387-93.
Rao RA, Kransdorf EP, Patel JK, Kobashigawa JA, Kittleson MM. How to Approach HLA Sensitization in Heart Transplant Candidates. JACC Heart Fail. 2023;11(4):469-75.
Colvin MM, Cook JL, Chang PP, Hsu DT, Kiernan MS, Kobashigawa JA, et al. Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. Circulation. 2019;139(12):e553-e78.
Habal MV. Current Desensitization Strategies in Heart Transplantation. Front Immunol. 2021;12:702186.
Dronavalli VB, Banner NR, Bonser RS. Assessment of the potential heart donor: a role for biomarkers? J Am Coll Cardiol. 2010;56(5):352-61.
Zaroff J. Echocardiographic evaluation of the potential cardiac donor. J Heart Lung Transplant. 2004;23(9 Suppl):S250-2.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-70.
Dupuis S, Amiel JA, Desgroseilliers M, Williamson DR, Thiboutot Z, Serri K, et al. Corticosteroids in the management of brain-dead potential organ donors: a systematic review. British journal of anaesthesia. 2014;113(3):346-59.
Pinsard M, Ragot S, Mertes PM, Bleichner JP, Zitouni S, Cook F, et al. Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. Crit Care. 2014;18(4):R158.
Buchanan IA, Mehta VA. Thyroid hormone resuscitation after brain death in potential organ donors: A primer for neurocritical care providers and narrative review of the literature. Clin Neurol Neurosurg. 2018;165:96-102.
Cooper LB, Milano CA, Williams M, Swafford W, Croezen D, Van Bakel AB, et al. Thyroid hormone use during cardiac transplant organ procurement. Clinical transplantation. 2016;30(12):1578-83.
Holndonner-Kirst E, Nagy A, Czobor NR, Fazekas L, Dohan O, Kertai MD, et al. The Impact of l-Thyroxine Treatment of Donors and Recipients on Postoperative Outcomes After Heart Transplantation. Journal of cardiothoracic and vascular anesthesia. 2019;33(6):1629-35.
Mi Z, Novitzky D, Collins JF, Cooper DK. The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors. Clin Epidemiol. 2015;7:17-27.
Novitzky D, Mi Z, Sun Q, Collins JF, Cooper DK. Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis. Transplantation. 2014;98(10):1119-27.
Al-Khafaji A, Elder M, Lebovitz DJ, Murugan R, Souter M, Stuart S, et al. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. 2015;41(3):418-26.
McKeown DW, Ball J. Treating the donor. Current opinion in organ transplantation. 2014;19(2):85-91.
Abdelnour T, Rieke S. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2009;28(5):480-5.
Dimopoulou I, Tsagarakis S, Anthi A, Milou E, Ilias I, Stavrakaki K, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Critical care medicine. 2003;31(4):1113-7.
Plurad DS, Bricker S, Neville A, Bongard F, Putnam B. Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors. American journal of surgery. 2012;204(6):856-60; discussion 60-1.
Khush KK, Menza R, Nguyen J, Zaroff JG, Goldstein BA. Donor predictors of allograft use and recipient outcomes after heart transplantation. Circulation Heart failure. 2013;6(2):300-9.
Tryon D, Hasaniya NW, Jabo B, Razzouk AJ, Bailey LL, Rabkin DG. Effect of left ventricular dysfunction on utilization of donor hearts. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018;37(3):349-57.
Sibona A, Khush KK, Oyoyo UE, Martens TP, Hasaniya NW, Razzouk AJ, et al. Long-term transplant outcomes of donor hearts with left ventricular dysfunction. The Journal of thoracic and cardiovascular surgery. 2019;157(5):1865-75.
Mohamedali B, Bhat G, Zelinger A. Frequency and pattern of left ventricular dysfunction in potential heart donors: implications regarding use of dysfunctional hearts for successful transplantation. J Am Coll Cardiol. 2012;60(3):235-6.
Zaroff JG, Babcock WD, Shiboski SC, Solinger LL, Rosengard BR. Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant. 2003;22(4):383-8.
Kono T, Nishina T, Morita H, Hirota Y, Kawamura K, Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. The American journal of cardiology. 1999;84(5):578-82.
Zaroff JG, Babcock WD, Shiboski SC. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant. 2003;22(3):334-7.
Casartelli M, Bombardini T, Simion D, Gaspari MG, Procaccio F. Wait, treat and see: echocardiographic monitoring of brain-dead potential donors with stunned heart. Cardiovasc Ultrasound. 2012;10:25.
Bombardini T, Arpesella G, Maccherini M, Procaccio F, Potena L, Bernazzali S, et al. Medium-term outcome of recipients of marginal donor hearts selected with new stress-echocardiographic techniques over standard criteria. Cardiovasc Ultrasound. 2014;12:20.
Cheng A, Schumer EM, Trivedi JR, Van Berkel VH, Massey HT, Slaughter MS. Does Donor Cardiopulmonary Resuscitation Time Affect Heart Transplantation Outcomes and Survival? The Annals of thoracic surgery. 2016;102(3):751-8.
Galeone A, Lebreton G, Leprince P. Old Europe carefully looks at a new heart: Cardiac arrest-resuscitated donors should not be turned down for heart transplant at first glance. The Journal of thoracic and cardiovascular surgery. 2017;154(2):540.
Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2013;32(11):1090-5.
Quader M, Wolfe L, Katlaps G, Kasirajan V. Donor Heart Utilization following Cardiopulmonary Arrest and Resuscitation: Influence of Donor Characteristics and Wait Times in Transplant Regions. Journal of transplantation. 2014;2014:519401.
Grauhan O, Patzurek J, Hummel M, Lehmkuhl H, Dandel M, Pasic M, et al. Donor-transmitted coronary atherosclerosis. J Heart Lung Transplant. 2003;22(5):568-73.
Shemie SD, Ross H, Pagliarello J, Baker AJ, Greig PD, Brand T, et al. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ. 2006;174(6):S13-32.
Ivanes F, Cantrelle C, Genet T, Le Feuvre C, Legeai C, Jasseron C, et al. Performing diagnostic coronary angiography to evaluate high-risk cardiac donors: A French nationwide cohort study. International journal of cardiology. 2019;277:71-8.
Schweiger M, Kluber J, Bosch A, von Levinski D, Prenner G, Stiegler P, et al. Low incidence of coronary angiography in the evaluation process of the potential heart donor. Transplantation proceedings. 2014;46(10):3339-42.
Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2016;35(1):1-23.
Butts RJ, Toombs L, Kirklin JK, Schumacher KR, Conway J, West SC, et al. Waitlist Outcomes for Pediatric Heart Transplantation in the Current Era: An Analysis of the Pediatric Heart Transplant Society Database. Circulation. 2024.
Peled Y, Ducharme A, Kittleson M, Bansal N, Stehlik J, Amdani S, et al. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transplant. 2024;43(10):1529-628 e54.
Copeland H, Knezevic I, Baran DA, Rao V, Pham M, Gustafsson F, et al. Donor heart selection: Evidence-based guidelines for providers. J Heart Lung Transplant. 2023;42(1):7-29.
Brock MV, Salazar JD, Cameron DE, Baumgartner WA, Conte JV. The changing profile of the cardiac donor. J Heart Lung Transplant. 2001;20(9):1005-9.
Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. J Heart Lung Transplant. 2012;31(10):1052-64.
Young JB. Age before beauty: the use of "older" donor hearts for cardiac transplantation. J Heart Lung Transplant. 1999;18(5):488-91.
McCarthy JF, McCarthy PM, Massad MG, Cook DJ, Smedira NG, Kasirajan V, et al. Risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries? The Annals of thoracic surgery. 1998;65(6):1574-8; discussion 8-9.
Blanche C, Kamlot A, Blanche DA, Kearney B, Magliato KE, Czer LS, et al. Heart transplantation with donors fifty years of age and older. J Thorac Cardiovasc Surg. 2002;123(4):810-5.
Gupta D, Piacentino V, 3rd, Macha M, Singhal AK, Gaughan JP, McClurken JB, et al. Effect of older donor age on risk for mortality after heart transplantation. The Annals of thoracic surgery. 2004;78(3):890-9.
Weber DJ, Wang IW, Gracon AS, Hellman YM, Hormuth DA, Wozniak TC, et al. Impact of donor age on survival after heart transplantation: an analysis of the United Network for Organ Sharing (UNOS) registry. Journal of cardiac surgery. 2014;29(5):723-8.
Roig E, Almenar L, Crespo-Leiro M, Segovia J, Mirabet S, Delgado J, et al. Heart transplantation using allografts from older donors: Multicenter study results. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2015;34(6):790-6.
Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int. 2008;21(2):113-25.
Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2014;33(10):996-1008.
Li H, Tanaka K, Anzai H, Oeser B, Lai D, Kobashigawa JA, et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. Journal of the American College of Cardiology. 2006;47(12):2470-6.
Caforio AL, Tona F, Fortina AB, Angelini A, Piaserico S, Gambino A, et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2004;4(6):962-70.
Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2007;7(10):2388-95.
Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant. 2000;19(5):496-503.
Leone O, Gherardi S, Targa L, Pasanisi E, Mikus P, Tanganelli P, et al. Stress echocardiography as a gatekeeper to donation in aged marginal donor hearts: anatomic and pathologic correlations of abnormal stress echocardiography results. J Heart Lung Transplant. 2009;28(11):1141-9.
Dark JH. Safe and effective use of the extended donor heart. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2015;47(1):78-9.
Singh N, Raees MA, Zafar F. Donor considerations in pediatric heart transplantation. Transl Pediatr. 2019;8(4):284-9.
Westbrook TC, Morales DLS, Khan MS, Bryant R, Castleberry C, Chin C, et al. Interaction of older donor age and survival after weight-matched pediatric heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(5):554-8.
Hada T, Seguchi O, Kitahata N, Komeyama S, Mochizuki H, Watanabe T, et al. Heart transplantation with super-aged donors older than 65 years. JHLT Open. 2024;4:100083.
Bergenfeldt H, Stehlik J, Hoglund P, Andersson B, Nilsson J. Donor-recipient size matching and mortality in heart transplantation: Influence of body mass index and gender. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(9):940-7.
Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13(3):353-64; discussion 64-5.
Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914-56.
Khush KK, Kubo JT, Desai M. Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2012;31(5):459-66.
Gong TA, Joseph SM, Lima B, Gonzalez-Stawinski GV, Jamil AK, Felius J, et al. Donor predicted heart mass as predictor of primary graft dysfunction. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018;37(7):826-35.
Kransdorf EP, Kittleson MM, Benck LR, Patel JK, Chung JS, Esmailian F, et al. Predicted heart mass is the optimal metric for size match in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2019;38(2):156-65.
Miller RJH, Hedman K, Amsallem M, Tulu Z, Kent W, Fatehi-Hassanabad A, et al. Donor and Recipient Size Matching in Heart Transplantation With Predicted Heart and Lean Body Mass. Semin Thorac Cardiovasc Surg. 2021.
Sethi GK, Lanauze P, Rosado LJ, Huston C, McCarthy MS, Butman S, et al. Clinical significance of weight difference between donor and recipient in heart transplantation. J Thorac Cardiovasc Surg. 1993;106(3):444-8.
Hosenpud JD, Pantely GA, Morton MJ, Norman DJ, Cobanoglu AM, Starr A. Relation between recipient: donor body size match and hemodynamics three months after heart transplantation. J Heart Transplant. 1989;8(3):241-3.
Patel ND, Weiss ES, Nwakanma LU, Russell SD, Baumgartner WA, Shah AS, et al. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. Circulation. 2008;118(14 Suppl):S83-8.
Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord. 1999;23(9):936-42.
Kwon MH, Wong S, Kittleson M, Ardehali A, Laks H, Shemin RJ, et al. Selecting oversized donor cardiac allografts for patients with pulmonary hypertension may be unnecessary. Transplantation proceedings. 2014;46(5):1497-501.
Reed RM, Netzer G, Hunsicker L, Mitchell BD, Rajagopal K, Scharf S, et al. Cardiac size and sex-matching in heart transplantation : size matters in matters of sex and the heart. JACC Heart Fail. 2014;2(1):73-83.
Szugye NA, Lorts A, Zafar F, Taylor M, Morales DLS, Moore RA. Can virtual heart transplantation via 3-dimensional imaging increase the maximum acceptable donor size? The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2019;38(3):331-3.
Plasencia JD, Kamarianakis Y, Ryan JR, Karamlou T, Park SS, Nigro JJ, et al. Alternative methods for virtual heart transplant-Size matching for pediatric heart transplantation with and without donor medical images available. Pediatric transplantation. 2018;22(8):e13290.
UNOS. Predicted Heart Mass (PHM) Match Calculator. 2019.
Tao R, Hess TM, Kuchnia A, Hermsen J, Raza F, Dhingra R. Association of Size Matching Using Predicted Heart Mass With Mortality in Heart Transplant Recipients With Obesity or High Pulmonary Vascular Resistance. JAMA Netw Open. 2023;6(6):e2319191.
Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Jr., Hsich E, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2019;38(10):1056-66.
Kawabori M, Critsinelis AC, Hironaka CE, Chen FY, Zhan Y, Thayer KL, et al. Right ventricular undersizing is associated with increased 1-year mortality. The Journal of thoracic and cardiovascular surgery. 2021;161(3):1048-59 e3.
Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;52(25):2148-55.
Nakamura Y, Yoshioka D, Asanoi H, Miyagawa S, Yoshikawa Y, Hata H, et al. Effect of a reduced donor heart right ventricular distensibility on post-heart transplant haemodynamics. Interact Cardiovasc Thorac Surg. 2021;32(1):141-9.
Holzhauser L, Imamura T, Bassi N, Fujino T, Nitta D, Kanelidis AJ, et al. Increasing heart transplant donor pool by liberalization of size matching. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2019;38(11):1197-205.
Jeevanandam V. Improving the metrics for donor heart sizing. Journal of cardiac surgery. 2021;36(9):3250.
Kaczmarek I, Meiser B, Beiras-Fernandez A, Guethoff S, Uberfuhr P, Angele M, et al. Gender does matter: gender-specific outcome analysis of 67,855 heart transplants. The Thoracic and cardiovascular surgeon. 2013;61(1):29-36.
Shugh SB, Szugye NA, Zafar F, Riggs KW, Villa C, Lorts A, et al. Expanding the donor pool for congenital heart disease transplant candidates by implementing 3D imaging-derived total cardiac volumes. Pediatric transplantation. 2020;24(1):e13639.
Aziz S, Soine LA, Lewis SL, Kruse AP, Levy WC, Wehe KM, et al. Donor left ventricular hypertrophy increases risk for early graft failure. Transpl Int. 1997;10(6):446-50.
Weiss ES, Allen JG, Kilic A, Russell SD, Baumgartner WA, Conte JV, et al. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2012;31(3):266-73.
Jasseron C, Legeai C, Jacquelinet C, Nubret-Le Coniat K, Flecher E, Cantrelle C, et al. Optimization of heart allocation: The transplant risk score. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2019;19(5):1507-17.
Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol. 2008;51(12):1214-20.
Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, et al. Impact of donor left ventricular hypertrophy on survival after heart transplant. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(12):2755-61.
Kransdorf EP, Stehlik J. Donor evaluation in heart transplantation: The end of the beginning. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2014;33(11):1105-13.
Fonarow GC. How old is too old for heart transplantation? Curr Opin Cardiol. 2000;15(2):97-103.
Costanzo MR, Naftel DC, Pritzker MR, Heilman JK, 3rd, Boehmer JP, Brozena SC, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant. 1998;17(8):744-53.
Wong CK, Yeung AC. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existent donor atherosclerosis. J Heart Lung Transplant. 2001;20(8):858-64.
Marelli D, Laks H, Bresson S, Ardehali A, Bresson J, Esmailian F, et al. Results after transplantation using donor hearts with preexisting coronary artery disease. J Thorac Cardiovasc Surg. 2003;126(3):821-5.
Tenderich G, Koerner MM, Stuettgen B, Arusoglu L, Bairaktaris A, Hornik L, et al. Extended donor criteria: hemodynamic follow-up of heart transplant recipients receiving a cardiac allograft from donors > or = 60 years of age. Transplantation. 1998;66(8):1109-13.
Grauhan O, Siniawski H, Dandel M, Lehmkuhl H, Knosalla C, Pasic M, et al. Coronary atherosclerosis of the donor heart--impact on early graft failure. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2007;32(4):634-8.
Couto-Mallon D, Almenar-Bonet L, Barge-Caballero E, Hernandez-Perez FJ, Lopez-Azor Garcia JC, Valero-Masa MJ, et al. Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients. Journal of the American College of Cardiology. 2023;82(9):753-67.
Watanabe T, Seguchi O, Yanase M, Fujita T, Murata Y, Sato T, et al. Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis. Transplantation. 2017;101(6):1310-9.
Yamasaki M, Sakurai R, Hirohata A, Honda Y, Bonneau HN, Luikart H, et al. Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis. Transplantation. 2011;91(12):1406-11.
Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2013;32(10):951-64.
Foroutan F, Alba AC, Guyatt G, Duero Posada J, Ng Fat Hing N, Arseneau E, et al. Predictors of 1-year mortality in heart transplant recipients: a systematic review and meta-analysis. Heart. 2018;104(2):151-60.
Massad MG, Smedira NG, Hobbs RE, Hoercher K, Vandervoort P, McCarthy PM. Bench repair of donor mitral valve before heart transplantation. Ann Thorac Surg. 1996;61(6):1833-5.
Coskun KO, Coskun ST, El Arousy M, Amin Parsa M, Schulz U, Deyerling W, et al. Cardiac surgery after heart transplantation: coronary artery bypass grafting and heart valve replacement. Heart Surg Forum. 2007;10(2):E110-4.
Pawale A, Tang GH, Milla F, Pinney S, Adams DH, Anyanwu AC. Bench mitral valve repair of donor hearts before orthotopic heart transplantation. Circ Heart Fail. 2012;5(6):e96-7.
Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991;325(7):454-60.
Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, et al. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients. The New England journal of medicine. 2019;380(17):1606-17.
Haji SA, Avery RK, Yamani MH, Tuzcu EM, Crowe TD, Cook DJ, et al. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant. 2006;25(3):294-7.
Sise ME, Strohbehn IA, Bethea E, Gustafson JL, Chung RT. Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors. Current opinion in organ transplantation. 2019;24(3):351-7.
Kilic A, Hickey G, Mathier M, Sultan I, Gleason TG, Horn E, et al. Outcomes of Adult Heart Transplantation Using Hepatitis C-Positive Donors. J Am Heart Assoc. 2020;9(2):e014495.
Ruck JM, Zeiser LB, Zhou AL, Chidi AP, Winchester SL, Durand CM, et al. Trends in use and three-year outcomes of hepatitis C virus-viremic donor lung transplants for hepatitis C virus-seronegative recipients. The Journal of thoracic and cardiovascular surgery. 2023;165(4):1587-95 e2.
Ruck JM, Zhou AL, Zeiser LB, Alejo D, Durand CM, Massie AB, et al. Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients. JTCVS Open. 2022;12:269-79.
Filip I. HIV-positive donor hearts - a game changer for patients with HIV and organ failure? AIDS. 2023;37(8):N1-N2.
Wolfe CR, Ison MG, Practice ASTIDCo. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical transplantation. 2019;33(9):e13547.
Tomida M, Muraki M, Uemura K, Yamasaki K. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke. 1998;29(8):1584-7.
Tung PP, Olmsted E, Kopelnik A, Banki NM, Drew BJ, Ko N, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36(7):1567-9.
Venkateswaran RV, Ganesh JS, Thekkudan J, Steeds R, Wilson IC, Mascaro J, et al. Donor cardiac troponin-I: a biochemical surrogate of heart function. Eur J Cardiothorac Surg. 2009;36(2):286-92; discussion 92.
Grant JW, Canter CE, Spray TL, Landt Y, Saffitz JE, Ladenson JH, et al. Elevated donor cardiac troponin I. A marker of acute graft failure in infant heart recipients. Circulation. 1994;90(6):2618-21.
Hokl J, Cerny J, Nemec P, Studenik P, Simkova M. Troponin T serum levels in donors related to troponin T levels in recipients immediately after heart transplantation. Transplant Proc. 1999;31(1-2):137-8.
Potapov EV, Ivanitskaia EA, Loebe M, Mockel M, Muller C, Sodian R, et al. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation. 2001;71(10):1394-400.
Vijay P, Scavo VA, Morelock RJ, Sharp TG, Brown JW. Donor cardiac troponin T: a marker to predict heart transplant rejection. The Annals of thoracic surgery. 1998;66(6):1934-9.
Madan S, Saeed O, Shin J, Sims D, Goldstein D, Pina I, et al. Donor Troponin and Survival After Cardiac Transplantation: An Analysis of the United Network of Organ Sharing Registry. Circulation Heart failure. 2016;9(6).
Khush KK, Menza RL, Babcock WD, Zaroff JG. Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007;26(10):1048-53.
Liu Z, Perry LA, Penny-Dimri JC, Handscombe M, Overmars I, Plummer M, et al. Donor Cardiac Troponin for Prognosis of Adverse Outcomes in Cardiac Transplantation Recipients: a Systematic Review and Meta-analysis. Transplant Direct. 2022;8(1):e1261.
Tapaskar N, Wayda B, Malinoski D, Luikart H, Groat T, Nguyen J, et al. Donor Electrocardiogram Associations With Cardiac Dysfunction, Heart Transplant Use, and Survival: The Donor Heart Study. JACC Heart Fail. 2024;12(4):722-36.
Amir NL, Gerber IL, Edmond JJ, Langlands JM, Richards AM, Ruygrok PN. Plasma B-type natriuretic peptide levels in cardiac donors. Clin Transplant. 2009;23(2):174-7.
Dronavalli VB, Ranasinghe AM, Venkateswaran RJ, James SR, McCabe CJ, Wilson IC, et al. N-terminal pro-brain-type natriuretic peptide: a biochemical surrogate of cardiac function in the potential heart donor. Eur J Cardiothorac Surg. 2010;38(2):181-6.
Vorlat A, Conraads VM, Jorens PG, Aerts S, Van Gorp S, Vermeulen T, et al. Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation. J Heart Lung Transplant. 2012;31(6):579-84.
Birks EJ, Owen VJ, Burton PB, Bishop AE, Banner NR, Khaghani A, et al. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation. 2000;102(3):326-31.
Venkateswaran RV, Dronavalli V, Lambert PA, Steeds RP, Wilson IC, Thompson RD, et al. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. Transplantation. 2009;88(4):582-8.
Wagner FD, Jonitz B, Potapov EV, Qedra N, Wegscheider K, Abraham K, et al. Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation. 2001;104(12 Suppl 1):I192-6.
Wagner FD, Jonitz B, Potapov E, Qedra N, Wegscheider K, Weinmann E, et al. Procalcitonin: a donor-specific predictor of early graft failure and early graft failure mortality after heart transplantation. J Heart Lung Transplant. 2001;20(2):206.
Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(10):1037-46.
Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(10):1047-59.
Goldfarb SB, Levvey BJ, Cherikh WS, Chambers DC, Khush K, Kucheryavaya AY, et al. Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Lung and Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(10):1070-9.
Rossano JW, Cherikh WS, Chambers DC, Goldfarb S, Khush K, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36(10):1060-9.
Kirsch M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY. Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant. 1998;17(3):268-77.
Bourge RC, Naftel DC, Costanzo-Nordin MR, Kirklin JK, Young JB, Kubo SH, et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant. 1993;12(4):549-62.
Fernandez J, Aranda J, Mabbot S, Weston M, Cintron G. Overseas procurement of donor hearts: ischemic time effect on postoperative outcomes. Transplant Proc. 2001;33(7-8):3803-4.
Briganti EM, Bergin PJ, Rosenfeldt FL, Esmore DS, Rabinov M. Successful long-term outcome with prolonged ischemic time cardiac allografts. J Heart Lung Transplant. 1995;14(5):840-5.
Sunjaya AF, Sunjaya AP. Combating Donor Organ Shortage: Organ Care System Prolonging Organ Storage Time and Improving the Outcome of Heart Transplantations. Cardiovasc Ther. 2019;2019:9482797.
Cantin B, Kwok BW, Chan MC, Valantine HA, Oyer PE, Robbins RC, et al. The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation. 2003;76(9):1275-9.
Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. Journal of the American College of Cardiology. 2004;43(5):806-10.
Lund LH, Edwards LB, Dipchand AI, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2016;35(10):1158-69.
Singhal AK, Sheng X, Drakos SG, Stehlik J. Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc. 2009;41(9):3539-44.
Szabo G, Hackert T, Buhmann V, Sebening C, Vahl CF, Hagl S. Myocardial performance after brain death: studies in isolated hearts. Ann Transplant. 2000;5(4):45-50.
Mohamedali B, Bhat G, Tatooles A, Zelinger A. Neurogenic stress cardiomyopathy in heart donors. Journal of cardiac failure. 2014;20(3):207-11.
Berman M, Ali A, Ashley E, Freed D, Clarke K, Tsui S, et al. Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death? J Heart Lung Transplant. 2010;29(9):957-65.
Karamlou T, Shen I, Slater M, Crispell K, Chan B, Ravichandran P. Decreased recipient survival following orthotopic heart transplantation with use of hearts from donors with projectile brain injury. J Heart Lung Transplant. 2005;24(1):29-33.
Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Patel J, et al. Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant. 2002;21(6):623-8.
Baroldi G, Di Pasquale G, Silver MD, Pinelli G, Lusa AM, Fineschi V. Type and extent of myocardial injury related to brain damage and its significance in heart transplantation: a morphometric study. J Heart Lung Transplant. 1997;16(10):994-1000.
Waller DA, Thompson AM, Wrightson WN, Gould FK, Corris PA, Hilton CJ, et al. Does the mode of donor death influence the early outcome of lung transplantation? A review of lung transplantation from donors involved in major trauma. J Heart Lung Transplant. 1995;14(2):318-21.
Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998;65(12):1533-42.
Wahlers T, Cremer J, Fieguth HG, Dammenhayn L, Albes J, Schafers HJ, et al. Donor heart-related variables and early mortality after heart transplantation. J Heart Lung Transplant. 1991;10(1 Pt 1):22-7.
Hornik L, Tenderich G, Wlost S, Zittermann A, Minami K, Koerfer R. Organs from donors with primary brain malignancy: the fate of cardiac allograft recipients. Transplantation proceedings. 2004;36(10):3133-7.
Warrens AN, Birch R, Collett D, Daraktchiev M, Dark JH, Galea G, et al. Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation. 2012;93(4):348-53.
Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. The British journal of surgery. 2014;101(7):768-74.
Freimark D, Aleksic I, Trento A, Takkenberg JJ, Valenza M, Admon D, et al. Hearts from donors with chronic alcohol use: a possible risk factor for death after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1996;15(2):150-9.
Houyel L, Petit J, Nottin R, Duffet JP, Mace L, Neveux JY. Adult heart transplantation: adverse role of chronic alcoholism in donors on early graft function. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1992;11(6):1184-7.
Shea KJ, Sopko NA, Ludrosky K, Hoercher K, Smedira NG, Taylor DO, et al. The effect of a donor's history of active substance on outcomes following orthotopic heart transplantation. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2007;31(3):452-6; discussion 6.
Houser SL, MacGillivray T, Aretz HT. The impact of cocaine on the donor heart: a case report. J Heart Lung Transplant. 2000;19(6):609-11.
Freimark D, Czer LS, Admon D, Aleksic I, Valenza M, Barath P, et al. Donors with a history of cocaine use: effect on survival and rejection frequency after heart transplantation. J Heart Lung Transplant. 1994;13(6):1138-44.
Koerner MM, Tenderich G, Minami K, Morshuis M, Mirow N, Arusoglu L, et al. Extended donor criteria: use of cardiac allografts after carbon monoxide poisoning. Transplantation. 1997;63(9):1358-60.
Ogawa Y, Tenderich G, Minami K, Schulz U, Kleikamp G, Hornik L, et al. Successful use of a cardiac allograft from tricyclic antidepressant intoxication. Transplantation. 2003;76(8):1239-40.
Tenderich G, Dagge A, Schulz U, Holzinger J, Hornik L, Mirow N, et al. Successful use of cardiac allograft from serotonin antagonist intoxication. Transplantation. 2001;72(3):529.
MacGowan GA, Dark JH, Corris PA, Nair AR. Effects of drug abuse, smoking and alcohol on donor hearts and lungs. Transplant international : official journal of the European Society for Organ Transplantation. 2019;32(10):1019-27.
Okoh AK, Chan O, Schultheis M, Gupta M, Shah A, Gold J, et al. Association between increased-risk donor social behaviors and recipient outcomes after heart transplantation. Clinical transplantation. 2020;34(3):e13787.
Vieira JL, Cherikh WS, Lindblad K, Stehlik J, Mehra MR. Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2020;39(12):1341-50.
Hussain Z, Yu M, Wozniak A, Kim D, Krepostman N, Liebo M, et al. Impact of donor smoking history on post heart transplant outcomes: A propensity-matched analysis of ISHLT registry. Clinical transplantation. 2021;35(1):e14127.
Loupy A, Coutance G, Bonnet G, Van Keer J, Raynaud M, Aubert O, et al. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study. Circulation. 2020;141(24):1954-67.
Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard B, Rilo H, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 2001;130(4):660-6; discussion 6-8.
Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Cancer transmission from organ donors-unavoidable but low risk. Transplantation. 2012;94(12):1200-7.
Garrido G, Matesanz R. The Spanish National Transplant Organization (ONT) tumor registry. Transplantation. 2008;85(8 Suppl):S61-3.
Kransdorf EP, Rushakoff JA, Han J, Benck L, Malinoski D, Emerson D, et al. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2023;42(5):617-26.
Jeevanandam V, Furukawa S, Prendergast TW, Todd BA, Eisen HJ, McClurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. The Annals of thoracic surgery. 1996;62(5):1268-75.
Hunt SA, Baldwin J, Baumgartner W, Bricker JT, Costanzo MR, Miller L, et al. Cardiovascular management of a potential heart donor: a statement from the Transplantation Committee of the American College of Cardiology. Crit Care Med. 1996;24(9):1599-601.
Laks H, Marelli D, Fonarow GC, Hamilton MA, Ardehali A, Moriguchi JD, et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003;125(1):49-59.
Patel J, Kobashigawa JA. Cardiac transplantation: the alternate list and expansion of the donor pool. Curr Opin Cardiol. 2004;19(2):162-5.
Chen JM, Russo MJ, Hammond KM, Mancini DM, Kherani AR, Fal JM, et al. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. The Annals of thoracic surgery. 2005;80(1):224-8.
Felker GM, Milano CA, Yager JE, Hernandez AF, Blue L, Higginbotham MB, et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant. 2005;24(11):1781-6.
Arns W, Citterio F, Campistol JM. 'Old-for-old'--new strategies for renal transplantation. Nephrol Dial Transplant. 2007;22(2):336-41.
Maurer MS, Raina A, Hesdorffer C, Bijou R, Colombo P, Deng M, et al. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation. 2007;83(5):539-45.
Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88(2):231-6.
Rizzi G, Startseva X, Wolfrum M, Luscher TF, Ruschitzka F, Frohlich GM, et al. Unfavorable Donor Pretransplant APACHE II, SAPS II, and SOFA Scores Are Not Associated With Outcome: Implications for Heart Transplant Donor Selection. Transplantation proceedings. 2016;48(8):2582-7.
Fraser CD, 3rd, Grimm JC, Zhou X, Lui C, Giuliano K, Suarez-Pierre A, et al. Children's Heart Assessment Tool for Transplantation (CHAT) Score: A Novel Risk Score Predicts Survival After Pediatric Heart Transplantation. World J Pediatr Congenit Heart Surg. 2019;10(3):296-303.
Coutance G, Kransdorf E, Bonnet G, Loupy A, Kobashigawa J, Patel JK. Statistical performance of 16 posttransplant risk scores in a contemporary cohort of heart transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2021;21(2):645-56.
Powner DJ, Darby JM. Management of variations in blood pressure during care of organ donors. Prog Transplant. 2000;10(1):25-30; quiz 1-2.
Powner DJ, Kellum JA. Maintaining acid-base balance in organ donors. Prog Transplant. 2000;10(2):98-103; quiz 4-5.
Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43(6):852-4.
Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant. 1995;14(4):734-42.
Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997;7(1):139-45.
Hornby K, Ross H, Keshavjee S, Rao V, Shemie SD. Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study. Can J Anaesth. 2006;53(8):831-7.
McKeown DW, Bonser RS, Kellum JA. Management of the heartbeating brain-dead organ donor. Br J Anaesth. 2012;108 Suppl 1:i96-107.
Rayburn BK, Burton TM, Wannenburg T, Pennington DG, Oaks TE. Are efforts at expanding the donor pool misdirected? J Heart Lung Transplant. 1998;17(10):998-1003.
Potter CD, Wheeldon DR, Wallwork J. Functional assessment and management of heart donors: a rationale for characterization and a guide to therapy. J Heart Lung Transplant. 1995;14(1 Pt 1):59-65.
Stoica SC, Satchithananda DK, Charman S, Sharples L, King R, Rozario C, et al. Swan-Ganz catheter assessment of donor hearts: outcome of organs with borderline hemodynamics. J Heart Lung Transplant. 2002;21(6):615-22.
Powner DJ, Crommett JW. Advanced assessment of hemodynamic parameters during donor care. Prog Transplant. 2003;13(4):249-57; quiz 56-7.
Agrawal A, Timothy J, Cincu R, Agarwal T, Waghmare LB. Bradycardia in neurosurgery. Clin Neurol Neurosurg. 2008;110(4):321-7.
Szabo G, Hackert T, Sebening C, Vahl CF, Hagl S. Modulation of coronary perfusion pressure can reverse cardiac dysfunction after brain death. The Annals of thoracic surgery. 1999;67(1):18-25; discussion -6.
Anwar A, Lee JM. Medical Management of Brain-Dead Organ Donors. Acute Crit Care. 2019;34(1):14-29.
Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year review from a Level I trauma center. J Trauma. 1990;30(6):728-32.
Dictus C, Vienenkoetter B, Esmaeilzadeh M, Unterberg A, Ahmadi R. Critical care management of potential organ donors: our current standard. Clin Transplant. 2009;23 Suppl 21:2-9.
Kamarainen A, Virkkunen I, Tenhunen J. Hypothermic preconditioning of donor organs prior to harvesting and ischaemia using ice-cold intravenous fluids. Med Hypotheses. 2009;73(1):65-6.
Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand. 2009;53(10):1239-50.
Pandit RA, Zirpe KG, Gurav SK, Kulkarni AP, Karnath S, Govil D, et al. Management of Potential Organ Donor: Indian Society of Critical Care Medicine: Position Statement. Indian J Crit Care Med. 2017;21(5):303-16.
Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304(23):2620-7.
Powner DJ, Darby JM, Kellum JA. Proposed treatment guidelines for donor care. Prog Transplant. 2004;14(1):16-26; quiz 7-8.
Dominguez-Roldan JM, Jimenez-Gonzalez PI, Garcia-Alfaro C, Hernandez-Hazanas F, Fernandez-Hinojosa E, Bellido-Sanchez R. Electrolytic disorders, hyperosmolar states, and lactic acidosis in brain-dead patients. Transplant Proc. 2005;37(5):1987-9.
Yellon DM, Baxter GF. Sodium-hydrogen exchange in myocardial reperfusion injury. Lancet. 2000;356(9229):522-3.
Kaczmarek I, Groetzner J, Mueller M, Landwehr P, Uberfuhr P, Nollert G, et al. Impact of donor serum sodium levels on outcome after heart transplantation. J Heart Lung Transplant. 2005;24(7):928-31.
Powner DJ, Hernandez M. A review of thyroid hormone administration during adult donor care. Prog Transplant. 2005;15(3):202-7.
Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand. 2009;53(4):425-35.
Gelb AW, Robertson KM. Anaesthetic management of the brain dead for organ donation. Can J Anaesth. 1990;37(7):806-12.
Cerutti E, Stratta C, Romagnoli R, Serra R, Lepore M, Fop F, et al. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl. 2006;12(8):1253-9.
Meyfroidt G, Gunst J, Martin-Loeches I, Smith M, Robba C, Taccone FS, et al. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality. Intensive Care Med. 2019;45(3):343-53.
Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, et al. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect. 2014;20 Suppl 7:10-8.
Freeman RB, Giatras I, Falagas ME, Supran S, O'Connor K, Bradley J, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation. 1999;68(8):1107-11.
Lumbreras C, Sanz F, Gonzalez A, Perez G, Ramos MJ, Aguado JM, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis. 2001;33(5):722-6.
Ruiz I, Gavalda J, Monforte V, Len O, Roman A, Bravo C, et al. Donor-to-host transmission of bacterial and fungal infections in lung transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6(1):178-82.
Bahrami T, Vohra HA, Shaikhrezai K, Tadjkarimi S, Banner N, Amrani M, et al. Intrathoracic organ transplantation from donors with meningitis: a single-center 20-year experience. The Annals of thoracic surgery. 2008;86(5):1554-6.
Webb WR, Howard HS, Neely WA. Practical methods of homologous cardiac transplantation. The Journal of thoracic surgery. 1959;37(3):361-6.
Shumway NE, Lower RR, Stofer RC. Selective hypothermia of the heart in anoxic cardiac arrest. Surgery, gynecology & obstetrics. 1959;109:750-4.
Cass MH, Brock R. Heart excision and replacement. Guys Hosp Rep. 1959;108:285-90.
Bretschneider HJ, Hubner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. The Journal of cardiovascular surgery. 1975;16(3):241-60.
Li Y, Guo S, Liu G, Yuan Y, Wang W, Zheng Z, et al. Three Preservation Solutions for Cold Storage of Heart Allografts: A Systematic Review and Meta-Analysis. Artif Organs. 2016;40(5):489-96.
Wicomb WN, Cooper DK, Novitzky D, Barnard CN. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. The Annals of thoracic surgery. 1984;37(3):243-8.
Dhital KK, Iyer A, Connellan M, Chew HC, Gao L, Doyle A, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet. 2015;385(9987):2585-91.
Celik A, Lindstedt S, McGiffin DC, Suen JY, Fraser JF, Del Nido PJ, et al. Revitalizing donor organs: The potential of mitochondrial transplantation in heart and lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2025;44(10):1648-58.
Moskowitzova K, Shin B, Liu K, Ramirez-Barbieri G, Guariento A, Blitzer D, et al. Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2019;38(1):92-9.
Doulamis IP, Nomoto RS, Tzani A, Hong X, Duignan T, Celik A, et al. Transcriptomic and proteomic pathways of diabetic and non-diabetic mitochondrial transplantation. Sci Rep. 2022;12(1):22101.
Guariento A, Piekarski BL, Doulamis IP, Blitzer D, Ferraro AM, Harrild DM, et al. Autologous mitochondrial transplantation for cardiogenic shock in pediatric patients following ischemia-reperfusion injury. The Journal of thoracic and cardiovascular surgery. 2021;162(3):992-1001.
